SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is attracting significant community attention and discussion, particularly as its proponents rally around the upcoming 4/20 event, promoting its mission to advance global cannabis culture and legalization on the Solana blockchain as a crypto 'like Bitcoin but way higher'.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly active community's relentless focus on building a "permissionless brand," highlighted by the continuous launch of real-world products like "Kendu Spice" and "Kendu Unleashed" skateboards. The community remains overwhelmingly bullish, emphasizing the project's strong fundamentals and long-term vision amidst prevailing market conditions.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is experiencing a strong rally, propelled by increasing market conviction in AI's transformative role in drug discovery, significant M&A activity, and growing expectations for rate cuts that are driving a sector-wide breakout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amidst community frustration and significant losses as the biotech sector (XBI) maintains an unexpected bull run, driven by ongoing M&A and perceived market manipulation, defying numerous bearish technical indicators.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST is capturing attention as the "privacy layer of Solana," bolstered by integrations with Solflare and partnerships like Zebec, with its low market cap sparking community excitement for substantial growth and utility in the current market.

WorldFinancial

WLFI is trending as it faces a U.S. House investigation into a significant $500 million investment deal, sparking a polarized community debate. While many critics denounce it as a politically-linked "scam," proponents are aggressively buying dips, anticipating future growth from its planned app and real-world asset tokenization initiatives.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

ProShares Short Bitcoin Strategy ETF (BITI) is actively discussed as a means to capitalize on Bitcoin's recent volatility and potential for further price declines, with many in the community seeing it as a strategic short or hedge amidst ongoing debate over the broader crypto market's direction.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is trending amid overwhelming analyst upgrades that have significantly raised price targets, fueled by robust sales of its MASH drug, Rezdiffra, since its market launch. The community is actively debating strong M&A potential in the heating MASH sector, further amplified by recent competitor acquisitions and Madrigal's expanding pipeline with promising data for advanced fibrosis.

Core Scientific, Inc. engages in the business of operating a purpose-built facility for digital asset mining and provision of blockchain infrastructure, software solutions, and services. It operates under the Mining and Hosting segments. The Mining segment focuses on bitcoin mining for the company's own account. The Hosting segment includes blockchain infrastructure and third-party hosting business. The company was founded by Michael Jeffrey Levitt and Darin Feinstein on December 13, 2017 and is headquartered in Dover, DE.

Core Scientific Inc - Ordinary Shares - New

Core Scientific Inc

A recent analyst upgrade to Buy, citing Core Scientific's AI infrastructure pivot and strong demand for high-performance computing, is currently battling significant selling pressure. The community is actively discussing perceived delays in its data center capacity delivery, particularly impacting a major client, which has reignited debates over past strategic decisions and the stock's future trajectory.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors seek a flight to safety, with the dividend-focused ETF holding strong and showing green performance during broader market downturns. The community is actively discussing a potential rotation from high-growth tech into value and income strategies, reinforcing SCHD's appeal as a long-term, defensive holding.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on...

Niagen Bioscience (NASDAQ:NAGE) Shares Down 3.4% - Here's What Happened

Niagen Bioscience (NASDAQ:NAGE) Stock Price Down 3.4% - Time to Sell...

Niagen Bioscience Expands HSA/FSA Access for Tru Niagen, the Leading NAD+ Supplement in the U.S.*

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it has partnered with...

Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) have been given an average rating of "Moderate Buy" by the five analysts that are covering the firm, Marketbeat reports. One...

Precision Wealth Strategies LLC Makes New $1.53 Million Investment in Niagen Bioscience, Inc. $NAGE

Precision Wealth Strategies LLC bought a new stake in Niagen Bioscience, Inc. (NASDAQ:NAGE - Free Report) in the third quarter, according to the company in its most recent 13F filing with the...

Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queens University Belfast

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has acquired a...

Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Moderate Buy" from Brokerages

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the five research firms that are presently covering the company, Marketbeat...

Niagen Bioscience (NASDAQ:NAGE) CFO Acquires 4,465 Shares

Niagen Bioscience, Inc. (NASDAQ:NAGE - Get Free Report) CFO Ozan Pamir bought 4,465 shares of the stock in a transaction dated Friday, November 14th. The stock was bought at an average price of $6.81...

Niagen Bioscience Launches Tru Niagen Beauty The First NAD+ Skincare Supplement in the U.S. Featuring Niagen (Patented Nicotinamide Riboside)

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen Beauty...

Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the...

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Current Price	$5.17
Prev Close	$5.13
Open	$5.20
Dividend Yield	0.00%
50-Day Moving Average	$6.35
Beta	1.38
Avg. Volume	811,872.55
PE Ratio	21.36

52-Week High	$14.69
52-Week Low	$5.05
Market Capitalization	$414.99M
EPS (Annual)	$0.1094
Price to Book	5.86
Revenue Per Employee	$957,663.46
Enterprise Value/EBITDA	N/A

NAGE
Niagen Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NAGE News

NAGENiagen Bioscience Inc.